@article{article, title  = {{Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 url = {{http://eprints.whiterose.ac.uk/137968/ }},

 year = {{2018}},

 month = {{9}},

 author = {{Tappenden P and Simpson E and Hamilton J and Pollard D and Clowes M and Kaltenthaler E and Meiklejohn D and Morley N}},

 doi = {{10.1007/s40273-018-0713-7}},

 journal = {{PharmacoEconomics}},

 note = {{Accessed on 2024/12/22}}}